Company Filing History:
1 out of 1,744 
1 out of 5 Years Active: 2016
Title: Christiane Susini: Innovator in Pancreatic Gene Therapy
Introduction
Christiane Susini is a prominent inventor based in Lanta, France. She has made significant contributions to the field of gene therapy, particularly in the treatment of cancer. Her innovative work has led to the development of a patent that addresses critical aspects of pancreatic gene therapy.
Latest Patents
Christiane Susini holds a patent for a groundbreaking invention titled "Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy." This patent involves products containing nucleic acid sequences coding for the human somatostatin 2 receptor protein, deoxycytidine kinase protein, and uridine monophosphate kinase protein, along with gemcitabine. The invention aims to provide a combined preparation for the simultaneous, separate, or sequential use in treating cancer in a subject. She has 1 patent to her name.
Career Highlights
Throughout her career, Christiane has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Cayla. Her experience in these institutions has allowed her to advance her research and contribute to significant medical innovations.
Collaborations
Christiane has collaborated with notable professionals in her field, including Louis Buscail and Gérard Tiraby. These partnerships have enriched her research and expanded the impact of her work in gene therapy.
Conclusion
Christiane Susini is a trailblazer in the realm of pancreatic gene therapy, with her innovative patent paving the way for new cancer treatments. Her contributions to the field highlight the importance of research and collaboration in advancing medical science.